Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size.

[1]  E. Gelmann,et al.  Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. , 2005, Cancer research.

[2]  O. Grace,et al.  Sonic hedgehog regulates prostatic growth and epithelial differentiation. , 2003, Developmental biology.

[3]  T. Bjørge,et al.  Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men , 2003, British Journal of Cancer.

[4]  Jing Ma,et al.  Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function. , 2002, Cancer research.

[5]  J. Gohagan,et al.  Relationship of demographic and clinical factors to free and total prostate-specific antigen. , 2001, Urology.

[6]  C. Roehrborn,et al.  Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination. , 2001, Urology.

[7]  R. Schwartz,et al.  The Smooth Muscle γ-Actin Gene Promoter Is a Molecular Target for the Mouse bagpipe Homologue, mNkx3-1, and Serum Response Factor* , 2000, The Journal of Biological Chemistry.

[8]  John K. Gohagan,et al.  The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial , 2000 .

[9]  J. Gohagan,et al.  Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. , 2000, Controlled clinical trials.

[10]  J. Clemens,et al.  Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development. , 1999, The Journal of urology.

[11]  M. Augustus,et al.  Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. , 1997, Cancer research.

[12]  M. Fishman,et al.  Zebrafish tinman homolog demarcates the heart field and initiates myocardial differentiation. , 1996, Development.

[13]  W. Hop,et al.  The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. , 1995, British journal of urology.

[14]  H. Guess.  Epidemiology and natural history of benign prostatic hyperplasia. , 1995, The Urologic clinics of North America.

[15]  S. Vesey.  PSA/prostate volume ratio. , 1994, British journal of urology.

[16]  J. Oesterling,et al.  The origin and development of benign prostatic hyperplasia. An age-dependent process. , 1991, Journal of andrology.

[17]  J. McNeal,et al.  Pathology of benign prostatic hyperplasia. Insight into etiology. , 1990, The Urologic clinics of North America.

[18]  P. Cooke,et al.  Stromal-epithelial interactions in adult organs. , 1985, Cell differentiation.

[19]  P. Walsh,et al.  The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.

[20]  William J Catalona,et al.  Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography. , 2005, The Journal of urology.

[21]  R. Cooper,et al.  Height and risk of fatal prostate cancer: findings from the National Health Interview Survey (1986 to 1994). , 2001, Annals of epidemiology.

[22]  J. McNeal.  Origin and evolution of benign prostatic enlargement. , 1978, Investigative urology.